Single-use i-STAT test cartridges cover a large menu of commonly used tests in one platform. This handheld analyzer operates with the advanced technology of single-use i-STAT test cartridges. Provides faster results than bench-top analyzersĪllows quick response to any need or change in a patient’s condition It also transmits results wirelessly to the Electronic Medical Record (EMR). This revolutionary, handheld analyzer provides reliable test results in just minutes rather than hours, using as little as two drops of blood and a test cartridge, making it invaluable in near patient testing applications.
Istat point of care portable#
Portable and easy to use, the unit performs a complete panel of tests from a single platform, enabling physicians to monitor and manage their patients quickly and effectively. The i-STAT system benefits hospitals, laboratories and other healthcare facilities with the industry’s most comprehensive menu of tests on a single point-of-care platform. The system drives performance and efficiency at each stage of the patient journey, from the time spent waiting to be seen through to treatment, discharge or admission. It allows the healthcare team to stay with the patient during testing to deliver collaborative, patient-centered care. The Abbott i-STAT System is an advanced, easy-to-use handheld analyzer that provides healthcare professionals with access to real time, lab quality results within minutes rather than hours. They provide accurate results in real time, supporting quick therapeutic decisions. Point-of-care analyzers reduce the time and labor required to collect, process, and report results.
Colors, lights, and sound snake it clear when results are in the critical range, and require immediate action (as compared to results that are abnormal, or in the normal stage). It also makes it easy for healthcare providers to understand results, fast. Provides on-screen guidance during testingĪnd identifies problems and potential solutions in real time From the color of the touchscreen, to the durable design, every aspect of the system lets the user have more, better control. See, we told you it was easy! It was designed to be.
Istat point of care software#
Step 4: Upload information automatically into the LIS/HIS through the Data Management Software Step 3: View the results on the handheld screen within minutes. Step 2: Close the cartridge and insert into the i-STAT handheld. Step 1: Insert two or three drops of blood into the cartridge. Testing can be performed at the patient’s side, with only 2-3 drops of whole blood. The i-STAT POC cTnI assay can be added to the list of assays for risk stratification.The Abbot i-STAT 1 system is so easy to use, we only had to write four steps down. reference concentrations before 30 days for ACD, MI or ACD, and MI or cardiac death. Kaplan-Meier curves showed early separation between patients with increased vs. Odds ratios and 95% confidence intervals for all-cause death (ACD), MI or ACD, MI or cardiac death, and cardiac death at 60 days were all statistically significant after adjustment for age, diabetes, hypertension, and history of renal failure as follows: 2.54 (1.24-5.20), P = 0.009 2.76 (1.37-5.58), P = 0.003 5.98 (1.65-21.7), P = 0.008 and 2.54 (1.24-5.20), P = 0.009. We computed survival and event curves with the Kaplan-Meier method and compared risk stratification groups with the log-rank test.Īcute myocardial infarction (MI) was diagnosed in 8.1% of patients. Patients were risk-stratified based on cTnI concentrations defined by the predetermined 99th percentile reference limit for plasma (0.04 microg/L). We measured plasma cTnI with the i-STAT assay. We studied consecutive patients (n = 367) presenting with symptoms suggestive of ACS who were admitted through the emergency department. We investigated the use of a POC cTnI assay in ACS patients. Few studies have investigated the role of cardiac troponin point-of-care (POC) testing for predicting adverse outcomes in acute coronary syndrome (ACS) patients.
0 kommentar(er)
